| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Revenue | $153K | -11.5% |
| R&D Expense | $11.4M | -34.4% |
| SG&A Expense | $10.0M | -51.1% |
| Operating Income | -$21.1M | +1.0% |
| Income Tax | $0 | — |
| Net Income | -$21.1M | +1.0% |
| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.0M | -76.5% |
| Inventory | $102K | -86.0% |
| Current Assets | $8.0M | -78.1% |
| Total Assets | $20.6M | -49.3% |
| Current Liabilities | $2.4M | -32.5% |
| Long-term Debt | $3.5M | -1.5% |
| Total Liabilities | $6.4M | -6.1% |
| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.0M | +48.3% |
| Capital Expenditures | $5.2M | +6282.7% |
| Investing Cash Flow | -$5.6M | -126.5% |
| Financing Cash Flow | -$75K | -107.4% |
| Free Cash Flow | -$23.2M | +33.7% |
| Stockholders' Equity |
| $14.1M |
| -58.1% |